Internal Medicine, Medical Oncology · Deerfield Beach, FL
NPI
1750745063
Since 2016
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1192 E Newport Center Dr Ste 230j
Deerfield Beach, FL, 33442
Phone (954) 571-0111
Groups this clinician bills Medicare through
Medicare paid, 2024
$56K
862 services
Medicare patients, 2024
118
Average age 75
Drug cost, 2024
$1.2M
544 prescriptions
Company payments, 2025
$9,111
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Steven Bialick was code 99215 (office e&m - established), 290 times for 66 patients. In total Steven Bialick billed 862 services in 11 codes, and Medicare paid $56K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 290 | 66 | $110.68 | $32K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 245 | 71 | $13.18 | $3,229 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 132 | 51 | $24.91 | $3,288 |
| 99214 Office E&M - Established | Office | 87 | 48 | $75.44 | $6,563 |
| 99232 Hospital E&M - Subsequent | Facility | 33 | 21 | $65.75 | $2,170 |
| 99205 Office E&M - New | Office | 32 | 32 | $146.95 | $4,702 |
| 99222 Hospital E&M - Initial | Facility | 15 | 15 | $110.27 | $1,654 |
| 99213 Office E&M - Established | Office | 12 | 11 | $53.14 | $638 |
By year: 2023 $12K for 119 services; 2024 $56K for 862 services.
Medicare prescription drug claims, 2024
In 2024, the drug Steven Bialick prescribed most often to Medicare patients was Prochlorperazine Maleate, with 50 prescriptions and refills. In total Steven Bialick wrote 544 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prochlorperazine Maleate Generic | 50 | 50 | 37 | $525 |
| Ondansetron Odt Ondansetron | 46 | 46 | 33 | $959 |
| Levofloxacin Generic | 43 | 43 | 14 | $112 |
| Eliquis Apixaban | 42 | 44 | Under 11 | $25K |
| Oxycodone Hcl Generic | 30 | 30 | 12 | $451 |
| Tramadol Hcl Generic | 21 | 21 | 15 | $153 |
| Gabapentin Generic | 18 | 18 | Under 11 | $89.86 |
| Furosemide Generic | 17 | 25 | Under 11 | $20.55 |
| Methylprednisolone Generic | 15 | 15 | Under 11 | $78.16 |
| Lorazepam Generic | 14 | 14 | Under 11 | $113 |
| Stivarga Regorafenib | 13 | 13 | Under 11 | $301K |
| Creon Lipase/Protease/Amylase | 13 | 15 | Under 11 | $41K |
| Mirtazapine Generic | 12 | 18 | Under 11 | $171 |
| Anastrozole Generic | 12 | 12 | Under 11 | $8.5 |
Brand drugs: 120 claims; generic drugs: 424 claims; opioid claims: 67.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Steven Bialick $9,111 ($9,111 in general payments such as food, travel and fees) from 22 companies. The largest payer was SpringWorks Therapeutics, Inc. with $7,439.
| Company | Payments | Amount |
|---|---|---|
| SpringWorks Therapeutics, Inc. | 6 | $7,439 |
| Daiichi Sankyo Inc. 4568.T | 6 | $775 |
| Aadi Bioscience, Inc. | 1 | $142 |
| Janssen Biotech, Inc. JNJ | 4 | $86.51 |
| Taiho Oncology, Inc. 4578.T | 4 | $71.85 |
| Array Biopharma Inc PFE | 3 | $60.51 |
| Caris MPI, Inc. | 2 | $50.05 |
| Incyte Corporation INCY | 2 | $43.15 |
| Astellas Pharma US Inc 4503.T | 2 | $43.05 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $42.84 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.